http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013200732-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b74452a889073845b47a40e23c273814 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 2013-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e2b74bccd9bae8b49c14109c898141f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5674d0242b5fadc3dc4e3aedb8daa6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d5e1ba9cd30a64b465e9dc6bb7097c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f90915c5c3705534bcf159cefdda5e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08039f8d258f7f193d7c45129f3492f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f1ecd8b673aeb689a6a67541dacbc7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9fa014ce2cbfba51fa1c25f31b68361 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b954a6ce82acb6b407d20a869b8a8fc6 |
| publicationDate | 2013-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2013200732-A1 |
| titleOfInvention | 3,7-diamino-10H-phenothiazine salts and their use |
| abstract | This invention pertains generally to the field of phenothiazine compounds, and more particularly to certain stably reduced phenothiazine compounds, specifically, certain 3,7 diamino- OH-phenothiazine (DAPTZ) compounds of the following formula wherein: each of R1 and R9 is independently selected from: -H;C 1.4alkyl; Ci_4alkenyl; and halogenated C1.4alkyl; each of R3NA and R3NB is independently selected from: -H; C1 .4alkyl; C2-4alkenyl; and halogenated C1 .4alkyl; each of R7hA and R7 NB is independently selected from: -H; C1 4alkyl; C2-4alkenyl; and halogenated C1.4alkyl; each of HX' and HX 2 is independently a protic acid; and pharmaceutically acceptable salts, solvates, and hydrates thereof.; These compounds are useful as drugs, for example, in the treatment of tauopathies, such as Alzheimer's disease, and also as prodrugs for the corresponding oxidized thioninium drugs (for example, methythioninium chloride, MTC). 60 \ 20 C om pound -- B6 -20 -B1 0 200 400 600 800 1000 1200 Time (minutes) 25 - Compound - - --- - B3 ,... - B6 -25 --- BI 0 200 400 600 800 1000 1200 Time (minutes) |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10323010-B2 |
| priorityDate | 2006-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 441.